Asthma in Australia 2008 

Table A1.8
Classification of respiratory medications

Category
Medications included
DDDs/formulation
Short–acting beta–agonists Fenoterol

0.6 mg Inhalation aerosol

   
0.6 mg Inhalation powder
 
4 mg Inhalation solution
  Orciprenaline
60 mg Oral
  Salbutamol

0.8 mg Inhalation aerosol

 
0.8 mg Inhalation powder
 
10 mg Inhalation solution
  Terbutaline

2 mg Inhalation aerosol

 
2 mg Inhalation powder
 
20 mg Inhalation solution
Long–acting beta–agonists Salmeterol

0.1 mg Inhalation aerosol

 
0.1 mg Inhalation powder
(e)Formoterol

24 mcg Inhalation aerosol

 
24 mcg Inhalation powder
Short–acting anti–cholinergics Ipratropium

0.12 mg Inhalation aerosol

 
0.12 mg Inhalation powder
 
0.3 mg Inhalation solution
Long–acting anti–cholinergics Tiotropium bromide
18 mcg Inhalation powder
Cromones Cromoglycate

40 mg Inhalation aerosol

 
80 mg Inhalation powder
 
80 mg Inhalation solution
Nedocromil
8 mg Inhalation aerosol
Inhaled corticosteroids Beclomethasone

0.8 mg Inhalation aerosol

 
0.8 mg Inhalation powder
 
1.5 mg Inhalation solutio
Budesonide

0.8 mg Inhalation aerosol

 
0.8 mg Inhalation powder
 
1.5 mg Inhalation solution
Fluticasone

0.6 mg Inhalation aerosol

 
0.6 mg Inhalation powder
 
1.5 mg Inhalation solution
Xanithines Theophylline
0.4 g Oral
Choline theophyllinate
0.6 g Oral
Leukotriene receptor antagonists Montelukast
10 mg Oral
Zafirlukast
40 mg Oral

Note: DDD = defined daily dose

<< Return to List of Tables >>

<< Return to Table of Contents >>

 

© Australian Institute of Health and Welfare 2008